| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sensei Biotherapeutics, Inc. | Chief Operating Officer, Director | Employee Stock Option (right to buy) | 1,239,305 | 19 Feb 2026 | Direct | ||
| Sensei Biotherapeutics, Inc. | Chief Operating Officer, Director | Series B Preferred Stock | 809,822 | 17 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SNSE | Sensei Biotherapeutics, Inc. | 17 Feb 2026 | 4 | $0 | 4 | Chief Operating Officer, Director | 19 Feb 2026, 21:45 |
| SNSE | Sensei Biotherapeutics, Inc. | 17 Feb 2026 | 0 | $0 | 3 | Chief Operating Officer, Director | 19 Feb 2026, 21:44 |